Allergan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (46)

Latest Posts

About This Stock More About This Stock
J&J Back In Talks With Actelion, Teva Settles Corruption Probe
Article By: Arpita Dutt
Friday, December 23, 2016 1:37 PM EST
Several tuck-in deals and licensing agreements were announced this week while healthcare giant Johnson & Johnson is back in exclusive talks with Actelion regarding a possible deal.
In this article: AGN, JNJ, MRK, NVS, TEVA Also: BMY, PFE, LLY
Read
Allergan Slides After Mylan Granted Request For Review Of Restasis Patent
Article By: The Fly
Thursday, December 8, 2016 6:13 PM EST
Allergan shares are down 0.6% in late day trading, which is off the stock's earlier lows after news that Mylan Pharmaceuticals (MYL) filed a Petition requesting an inter partes review of a patent held by Allergan.
In this article: AGN, MYL
Read
E Better Than The Maestro
Article By: Vivian Lewis
Monday, November 28, 2016 11:53 PM EST
I hope my screed last week about frothy dry bulk carrier stocks persuaded you not to get into that thicket—or to sell out if you had been lured in. The group, led by Dryships, which we sold ages ago, duly crashed.
In this article: AGN, AZN, BCS, BHP, BP, CPA, CRH, CX, FCX, GSK, MINT, RBS, SLB, SAN, VALE, FCO, DGRLY, GTOMY, LMDCF, MXCHF, NPSNY, TCTZF, TESO, DRYS, INFY, TEVA, CUBA, GLD, MNILY, FBASF, VRGDF
Read
Lilly Alzheimer's Drug Fails, J&J In Acquisition Talks With ALIOF
Article By: Arpita Dutt
Monday, November 28, 2016 11:59 AM EST
Does Johnson & Johnson’s interest in acquiring Actelion imply the beginning of increased merger and acquisition (M&A) activity in the pharma and biotech sector?
In this article: AGN, AZN, BMY, JNJ, LLY, MRK, ALIOF
Read
A Trump Presidency Means Good Things For This Pharma Stock
Article By: Michael A Robinson
Monday, November 21, 2016 3:36 PM EST
Whatever Trump’s opinion, the overwhelming “Yes” vote on Nov. 8 just. unleashed a tsunami of cash. That tsunami is heading in the direction of marijuana companies – and in the direction of those companies’ investors.
In this article: AGN, GWPH
Read

PARTNER HEADLINES

Latest Tweets for $AGN

No tweets yet!

$AGN

Valeant Edges Up 15% After Announcing That It Will Acquire Salix
Terry Caruso 2/24/2015 8:20:44 PM

You said the company tried to acquire Allergan but the deal fell through because Valeant didn't like it's large R&D program. If true, why did it try to acquire $AGN in the first place?

1 to 1 of 1 comments